Autoimmune hepatitis: Of host and pathogen

Hepatology

Volumn 47, Issue 6, 2008, Pages 2147-2148

  Rigopoulou, Eirini I ^a,b   Dalekos, George N ^a,b  

^a UNIVERSITY OF THESSALY   (Greece)

^b INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOCHROME P450 2D6;

ANTIBODY DETECTION; AUTOIMMUNE HEPATITIS; HEPATITIS C VIRUS; HUMAN; IMMUNOFLUORESCENCE; LETTER; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HEPATITIS B VIRUS; IMMUNOLOGY; NOTE; PATHOGENICITY;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOCHROME P-450 CYP2D6; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS, AUTOIMMUNE; HUMANS;

EID: 46249109597     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22002     Document Type: Letter

References (15)

1. Longhi MS, Hussain MJ, Bogdanos DP, Quaglia A, Mieli-Vergani G, Ma Y, et al. Cytochrome P450IID6-specific CD 8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. HEPATOLOGY 2007;46:472-484.
2. Kammer AR, van der Burg SH, Grabscheid B, Hunziker IP, Kwappenberg KM, Reichen J, et al. Molecular mimicry of cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition. J Exp Med 1999;190:169-176.
3. Dalekos GN, Obermayer-Straub P, Bartels M, Maeda T, Kayser A, Loges S, et al. Cytochrome P450 2A6: a new hepatic autoantigen in chronic hepatitis C virus infection. J Hepatol 2003;39:800-806.
4. Lauer GM, Barnes E, Lucas M, Timm J, Ouchi K, Kim AY, et al. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology 2004;127:924-936.
5. Ma Y, Bogdanos DP, Hussain MJ, Underhill J, Bansal S, Longhi MS, et al. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology 2006;130:868-882.
6. Mackie FD, Peakman M, Yun M, Sallie R, Smith H, Davies ET, et al. Primary and secondary liver/kidney microsomal autoantibody response following infection with hepatitis C virus. Gastroenterology 1994;106:1672-1675.
7. Manns MP, Vogel A. Autoimmune hepatitis, from mechanisms to therapy. HEPATOLOGY 2006;43(Suppl):S132-S144.
8. Bogdanos DP, Choudhuri K, Vergani D. Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver 2001;21:225-232.
9. Vergani D, Choudhuri K, Bogdanos DP, Mieli-Vergani G. Pathogenesis of autoimmune hepatitis. Clin Liver Dis 2002;6:727-737.
10. Dalekos GN, Zachou K, Liaskos C, Gatselis N. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview. Eur J Intern Med 2002;13:293-303.
11. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006;354:54-66.
12. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938.
13. Zachou K, Rigopoulou E, Dalekos GN. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis 2004;1:2.
14. Muratori L, Lenzi M, Cataleta M, Giostra F, Cassani F, Ballardini G, et al. Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol 1994;21:199-203.
15. Dalekos GN, Wedemeyer H, Obermayer-Straub P, Kayser A, Barut A, Frank H, et al. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment. J Hepatol 1999;30:366-375.